Vitamin D Eksikliği Koroner Arter Hastalığı İçin Öngördürücü müdür?
Amaç: D vitamininin ve koroner arter hastalığının (KAH) ilişkisiyle ilgili ortaya çıkan verilere dayanarak, KAH'da D vitamini ile C-reaktif protein (CRP) ile temsil edilen inflamasyon ve serum lipid profili arasında ilişki bulunup bulunmadığını araştırdık. Materyal ve Metot: Yeni KAH tanısı konmuş 115 hasta ve 62 sağlıklı birey çalışmaya alındı. Kan lipidleri, CRP ve D vitamini düzeyleri ölçüldü ve hasta ve kontrol gruplarının değerleri karşılaştırıldı. Bulgular: Hasta grubunda düşük dansiteli lipoprotein kolesterol (DDL-K), CRP ve trigliserit düzeyleri yüksek, vitamin D ve yüksek dansiteli lipoprotein kolesterol (YDLK) düşüktü. Vitamin D ile YDL-K arasında pozitif korelasyon (r=0.328; p
CAN VITAMIN D DEFICIENCY PREDICT CORONARY ARTERY DISEASE?
Aim: On the basis of emerging data about the associationof vitamin D and coronary artery disease (CAD), weinvestigated whether a relationship exists among vitaminD, inflammation represented by C-reactive protein (CRP),and serum lipid profile in CAD.Materials and Methods: Patients with newly diagnosedCAD (n = 115) and 62 healthy subjects were enrolled inthe study. Blood lipids, CRP, and vitamin D levels weremeasured, and the patient and control groups’ values werecompared.Results: The low-density lipoprotein cholesterol (LDL-C),triglyceride, and CRP levels were higher, and vitamin Dand high-density lipoprotein cholesterol (HDL-C) levelswere lower in the patient group. A positive correlation wasfound between the vitamin D and HDL-C levels (r=0.328;p
___
- Nabel EG, Braunwald E. A tale of coronary artery
disease and myocardial infarction. N Engl J Med.
2012; 366:54-63.
- Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ,
Duriez P. New risk factors for atherosclerosis and
patient risk assessment, Review. Circulation. 2004
;109 (23): III15-9.
- Ross R. Atherosclerosis – an inflammatory disease. N
Engl J Med. 1999;340(5):115–26.
- Hansson GK, Libby P. The immune response in
atherosclerosis: a double-edged sword. Nat Rev
Immunol. 2006;6(7):508-19.
- Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto
AM Jr, Kastelein JJ et al. For the JUPITER Study
Group. Rosuvastatin to prevent vascular events in men
and women with elevated C-reactive protein. N Engl J
Med. 2008;359(21):2195–207.
- van der Meer IM, de Maat MP, Bots ML, Breteler MM,
Meijer J, Kiliaan AJ, et al. Inflammatory mediators and
cell adhesion molecules as indicators of severity of
atherosclerosis: the Rotterdam Study.
ArteriosclerThromb Vasc Biol. 2002;22(5):838-42.
- Castelli WP, Garrison RJ, Wilson PW, Abbott RD,
Kalousdian S, Kannel WB. Incidence of
coronary heart disease and lipoprotein cholesterol
levels. The Framingham Study. JAMA.
1986;256(20):2835-8.
- Executive Summary of the Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel
on Detection Evaluation and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III).
JAMA. 2001;285(19):2486–97.
- Kontush A, Chapman MJ. Antiatherogenic small,
dense HDL-guardian angel of the arterial wall? Nat
Clin Pract Cardiovasc Med. 2006;3(3):144-53.
- Duffy D. Rader DJ. Update on strategies to increase
HDL quantity and function. Nat Rev Cardiol.
2009;6(7):455-63.
- Judd SE, Tangpricha V. Vitamin D deficiency and risk
for cardiovascular disease. Am J Med Sci.
2009;338(1):40-4.
- Holick MF. High prevalence of vitamin D inadequacy
and implications for health. Mayo Clin Proc.
2006;81(3):353-73.
- Nadir MA, Szwejkowski BR, Witham MD. Vitamin D
and cardiovascular prevention. Cardiovasc Ther.
2010;28: e5-12.
- Anderson JL, May HT, Horne BD, Bair TL, Hall NL,
Carlquist JF, Lappé et al. Intermountain Heart
Collaborative (IHC) Study Group. Relation of vitamin D
deficiency to cardiovascular risk factors disease status,
and incident events in a general healthcare population.
Am J Cardiol. 2010;106(7):963-8.
- Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D,
Howard PA. Vitamin D deficiency and supplementation
and relation to cardiovascular health. Am JCardiol.
2012;109(3):359-63.
- Seker T, Gür M, Yüksel Kalkan G, Kuloğlu O, Yıldız
Koyunsever N, Yıldıray Şahin D, et al. Serum 25-hydroxyvitamin D level and extent and complexity of
coronary artery disease. J Clin Lab Anal.
2014;28(1):52-8.
- Shor R, Tirosh A, Shemesh L, Krakover R, Bar Chaim
A, Mor A, et al. 25 hydroxyvitamin D levels in patients
undergoing coronary artery catheterization. Eur J
Intern Med. 2012;23(5):470-3.
- Michos ED, Streeten EA, Ryan KA, Rampersaud E,
Peyser PA, Bielak LF, et al. Serum 25-hydroxyvitamin
d levels are not associated with subclinical vascular
disease or C-reactive protein in the old order amish.
Calcif Tissue Int. 2009;84(3):195-202.
- Amer M, Qayyum R. Relation between serum 25-
hydroxyvitamin D and C-reactive protein in
asymptomatic adults (from the continuous National
Health and Nutrition Examination Survey 2001 to
2006). Am J Cardiol. 2012;109(2):226-30.
- Ashraf AP, Fisher G, Alvarez J, Dudenbostel T,
Calhoun DA, Szalai AJ, et al. Associations of CReactive
Protein to Indices of Vascular Health and the
Influence of Serum 25(OH)D Status in Healthy Adults.
J Nutr Metab. 2012, doi:10.1155/2012/475975.
- Chen WR, Qian YA, Chen YD, Shi Y, Yin DW, Wang
H, et al. The effects of low vitamin D on coronary
artery disease. Heart Lung Circ. 2014 ;23(4):314-9.
- Maki KC, Rubin MR, Wong LG, McManus JF, Jensen
CD, Marshall JW, et al. Serum 25-hydroxyvitamin D is
independently associated with high-density lipoprotein
cholesterol and the metabolic syndrome in men and
women. J Clin Lipidol. 2009;3(4):289-96.
- Schiller NB, Shah PM, Crawford M, DeMaria A,
Devereux R, Feigenbaum H, et al. Recommendations
for quantitation of the left ventricle by two-dimensional
echocardiography. American Society of
Echocardiography Committee on
Standards.Subcommittee on Quantitation of TwoDimensional
Echocardiograms. J Am Soc
Echocardiogr. 1989;2(5):358–67.
- Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ.
Prevalence of hypovitaminosis D in cardiovascular
diseases (from the National Health and Nutrition
Examination Survey 2001 to 2004). Am J Cardiol.
2008;102(11):1540-4.
- Syal SK, Kapoor A, Bhatia E, Sinha A, Kumar S,
Tewari S, et al. Vitamin D deficiency, coronary artery
disease and endothelial dysfunction: observations from
a coronary angiographic study in Indian patients. J
Invasive Cardiol. 2012;24(8):385-9.
- Ku YC, Liu ME, Ku CS, Liu TY, Lin SL. Relationship
between vitamin D deficiency and cardiovascular
disease. World J Cardiol. 2013;5(9):337-46.
- Gotto AM Jr. High-density lipoprotein cholesterol and
triglycerides as therapeutic targets for preventing and
treating coronary artery disease. Am Heart J.
2002;144(6):33-42.
- Alber HF, Wanitschek MM, de Waha S, Ladurner A,
Suessenbacher A, Dörler J, et al. High-density
lipoprotein cholesterol, C-reactive protein, and
prevalence and severity of coronary artery disease in
5641 consecutive patients undergoing coronary
angiography. Eur J ClinInvest. 2008;38(6):372-80.
- Schnatz PF, Jiang X, Vila-Wright S, Aragaki AK, Nudy
M, O'Sullivan DM, et al. Calcium/vitamin D
supplementation, serum 25-hydroxyvitamin D
concentrations, and cholesterol profiles in the
Women's Health Initiative calcium/vitamin D
randomized trial. Menopause. 2014;21(8):823-33.
- Kim M, Na W, Sohn C. Correlation between vitamin D
and cardiovascular disease predictors in overweight
and obese Koreans. J Clin Biochem Nutr.
2013;52(2):167-71.
- Kazlauskaite R, Powell LH, Mandapakala C, Cursio
JF, Avery EF, Calvin J. Vitamin D is associated with
atheroprotective high-density lipoprotein profile in
postmenopausal women. J ClinLipidol. 2010;4(2):113-
9.
- Rigby WF, Denome S, Fanger MW. Regulation of
lymphokine production and human T lymphocyte
activation by 1.25-dihydroxyvitamin D3. Specific
inhibition at the level of messenger RNA. J
ClinInvest.1987;79(6):1659-64.
- Patel S, Farragher T, Berry J, Bunn D, Silman A,
Symmons D. Association between serum vitamin D
metabolite levels and disease activity in patients with
early inflammatory polyarthritis. Arthritis Rheum.
2007;56(7):2143-9.